AeroRx Therapeutics Announces $21 Million Series A Financing to Advance Inhaled AERO-007, the First Nebulized LABA/LAMA for COPD, into Late-Stage Clinical Development

by | Oct 6, 2025 | Press Release

About Team Pipeline News Investors Contact About    Team    Pipeline    News    Investors   Contact About    Team    Pipeline News    Investors   Contact Press Release AeroRx Therapeutics Announces $21 Million Series A Financing to Advance Inhaled AERO-007, the First...